Johann de Bono Selected Research

Nivolumab

10/2021

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johann de Bono Research Topics

Disease

97	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 06/2008
71	Neoplasms (Cancer) 01/2023 - 01/2003
14	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2009
11	Pain (Aches) 01/2023 - 11/2013
8	Disease Progression 01/2022 - 02/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
4	Nausea 11/2022 - 01/2015
4	Fatigue 11/2022 - 01/2015
4	Diarrhea 11/2022 - 01/2017
3	Carcinogenesis 12/2023 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2023 - 02/2007
3	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 01/2003
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2024 - 12/2018
2	Exanthema (Rash) 01/2023 - 01/2017
2	Anemia 11/2022 - 01/2020
2	Neutropenia 01/2022 - 03/2016
2	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2016
2	Asthenia 10/2021 - 01/2017
2	Infections 01/2021 - 12/2005
2	Bone Diseases (Bone Disease) 01/2017 - 10/2016
2	Carcinoma (Carcinomatosis) 04/2014 - 10/2008
1	Ovarian Neoplasms (Ovarian Cancer) 11/2022
1	Pneumonia (Pneumonitis) 11/2022
1	Cough 11/2022

Drug/Important Bio-Agent (IBA)

21	Docetaxel (Taxotere)FDA Link 05/2024 - 01/2013
21	enzalutamideIBA 05/2024 - 09/2014
17	abirateroneIBA 05/2024 - 01/2013
13	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 01/2013
12	AndrogensIBA 01/2022 - 08/2011
11	olaparibIBA 01/2023 - 01/2018
10	Hormones (Hormone)IBA 01/2023 - 06/2008
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2006
9	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 11/2013
9	cabazitaxel FDA Link 10/2021 - 03/2016
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2015
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2011
8	taxaneIBA 01/2023 - 08/2015
7	Abiraterone AcetateIBA 05/2024 - 01/2013
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 10/2016
5	AntigensIBA 12/2023 - 01/2021
5	Prednisone (Sone)FDA LinkGeneric 01/2023 - 02/2014
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
3	Phosphotransferases (Kinase)IBA 05/2024 - 01/2018
3	SteroidsIBA 12/2023 - 01/2013
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 06/2009
3	LigandsIBA 12/2021 - 10/2007
3	ErbB Receptors (EGF Receptor)IBA 12/2021 - 02/2007
3	AfatinibIBA 11/2018 - 12/2013
3	Lapatinib (GW572016)FDA Link 02/2013 - 02/2007
2	xentuzumabIBA 10/2023 - 01/2020
2	Circulating Tumor DNAIBA 01/2023 - 01/2023
2	Lutetium-177IBA 01/2023 - 01/2022
2	EnzymesIBA 01/2023 - 02/2013
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2018
2	talazoparibIBA 01/2023 - 01/2017
2	ipatasertibIBA 01/2023 - 01/2023
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2022 - 05/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022 - 09/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2022 - 01/2020
2	PhosphoproteinsIBA 01/2022 - 01/2016
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 12/2021 - 01/2003
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2021 - 01/2017
2	Neutralizing AntibodiesIBA 01/2021 - 01/2008
2	rucaparibIBA 10/2020 - 01/2018
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2018
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 10/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2018 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 06/2008
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 04/2015
2	dactolisibIBA 01/2017 - 01/2017
2	TensinsIBA 01/2017 - 04/2015
2	LuciferasesIBA 01/2017 - 04/2014
2	NVP-BKM120IBA 01/2017 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2015 - 01/2008
2	cantuzumab mertansineIBA 10/2008 - 01/2003
1	capivasertibIBA 05/2024
1	Glycoproteins (Glycoprotein)IBA 12/2023
1	MutagensIBA 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	Insulin-Like PeptidesIBA 10/2023
1	Eukaryotic Initiation Factor-4EIBA 01/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023
1	tomivosertibIBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	SenotherapeuticsIBA 01/2023
1	GlycosyltransferasesIBA 01/2023

Therapy/Procedure

69	Castration 05/2024 - 08/2011
45	Therapeutics 12/2023 - 12/2005
16	Drug Therapy (Chemotherapy) 01/2023 - 01/2003
3	Immunotherapy 01/2023 - 08/2011
2	Radiotherapy 01/2022 - 01/2018
1	Transplantation 12/2023
1	Aftercare (After-Treatment) 01/2023